# Interpace Biosciences, Inc. (IDXG) insider trading, Q3 2026

Canonical: https://sec-api.dev/insider-trading/idxg

> 3 non-derivative transactions: 0 purchases, 0 sales. CIK 1054102.

| Date | Insider | Relationship | Code | Shares | Price | Owned after | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 2026-08-20 | McCarthy Christopher | Officer | M | 277009.0 | 0.0 | 323800.0 | https://www.sec.gov/Archives/edgar/data/1054102/000149315226039495/0001493152-26-039495-index.htm |
| 2026-08-20 | Burnell Thomas W. | Director, Officer | F | 581718.0 | 1.61 | 1455927.0 | https://www.sec.gov/Archives/edgar/data/1054102/000149315226039528/0001493152-26-039528-index.htm |
| 2026-08-20 | Burnell Thomas W. | Director, Officer | M | 1966763.0 | 0.0 | 2037645.0 | https://www.sec.gov/Archives/edgar/data/1054102/000149315226039528/0001493152-26-039528-index.htm |

Source: https://www.sec.gov/data-research/sec-markets-data/insider-transactions-data-sets

---
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.
API: https://sec-api.dev/docs · ChatGPT app: https://chatgpt.com/plugins/plugin_asdk_app_6ae0ef2436ac8191941dae8a4d732669 · Free key: https://sec-api.dev/sign-up